Cargando…
The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study †
Multisystem inflammatory syndrome in children (MIS-C) is a serious condition characterized by excessive inflammation that can arise as a complication of SARS-CoV-2 infection in children. While our understanding of COVID-19 and MIS-C has been advancing, there is still uncertainty regarding the optima...
Autores principales: | Basaran, Ozge, Batu, Ezgi Deniz, Kaya Akca, Ummusen, Atalay, Erdal, Kasap Cuceoglu, Muserref, Sener, Seher, Balık, Zeynep, Karabulut, Erdem, Kesici, Selman, Karagoz, Tevfik, Ozsurekci, Yasemin, Bilginer, Yelda, Cengiz, Ali Bulent, Ozen, Seza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296827/ https://www.ncbi.nlm.nih.gov/pubmed/37371276 http://dx.doi.org/10.3390/children10061045 |
Ejemplares similares
-
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases
por: Kaya Akca, Ummusen, et al.
Publicado: (2021) -
Two siblings with Majeed syndrome and neutropenia
por: Kasap Cuceoglu, Muserref, et al.
Publicado: (2022) -
Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods
por: Kaya Akca, Ümmüşen, et al.
Publicado: (2023) -
The difference of the inflammatory milieu in MIS-C and severe COVID-19
por: Gurlevik, Sibel Lacinel, et al.
Publicado: (2022) -
Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever
por: Sener, Seher, et al.
Publicado: (2023)